Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Mukaiyama Aldol Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979523A details a novel chiral metal complex catalyzing asymmetric Mukaiyama aldol reactions for high-purity pharmaceutical intermediates with reduced costs.
Patent CN111423351A discloses a novel chiral copper complex for asymmetric Mukaiyama Aldol reactions, offering high stereoselectivity and water tolerance for scalable API intermediate manufacturing.